China Medicine Revenue, Profits - CHME Annual Income Statement

Add to My Stocks
$0.06 $0.05 (45.45%) CHME stock closing price Jun 19, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking China Medicine stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for CHME which shows a YOY revenue growth of 20.71% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the China Medicine profit and loss statement for 2009 total to $6.71M. This line item shows that the operating expenses has increased compared with last year. Also check: China Medicine assets and China Medicine free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20092008
China Medicine Revenues or Net Sales
Cost Of Goods Sold (COGS)45.76M38.07M
China Medicine Gross Profit
Research & Development Expense1.45M-
Selling General & Admin Expense5.26M3.8M
Income Before Depreciation Depletion Amortization12.26M10.92M
Depreciation Depletion Amortization--
Non Operating Income-7.31M-
Interest Expense--
China Medicine Pretax Income
Provision for Income Taxes3.55M2M
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations1.4M9.12M
Extraordinary Items & Discontinued Operations--
China Medicine Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS15.41M15.31M
Average Shares used to compute Basic EPS15.27M15.17M
Income Before Nonrecurring Items8.95M9.13M
Income from Nonrecurring Items-7.23M-
China Medicine Earnings Per Share Basic Net
China Medicine Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.580.60
Preferred Dividends Acc Pd--
Dividends Common--
Dividend Per Share Common0.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on China Medicine stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that CHME stock has a topline or revenue of $64.75M for 2009 as per this China Medicine revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $1.4M for CHME stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The CHME financials along with China Medicine historical stock prices provide a lot of details about the firm.

China Medicine Income Statement - Key Financial Ratios

Annual Income Statements - China Medicine Corporation Industry Peers

China Sky One Medical income statement, GlobeImmune income statement, Parnell Pharma income statement